Hydrogen Peroxide Blocking Reagent (ab64218)

Publishing research using ab64218? Please let us know so that we can cite the reference in this datasheet.

ab64218 has been referenced in 1 publication.

  • Selby MJ  et al. Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS One 11:e0161779 (2016). PubMed: 27610613

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up